A @count_me_in research initiative to partner directly w patients to accelerate and share discoveries in Angiosarcoma. Please follow us there for updates!
We are improving how and when we communicate so that you have more timely, clear messages that give you continuous information about the Angiosarcoma Project - as well as our other projects. Please follow us at @count_me_in to stay up to date with us.
Great to see this in print!!!!! Beautiful paper and the most extensive correlatives to date for sarcoma immunotherapy… congratulations to all the authors!
We are improving how and when we communicate so that you have more timely, clear messages that give you continuous information about the Angiosarcoma Project - as well as our other projects. Please follow us at @count_me_in to stay up to date with us.
For those of you interested in learning more about a novel DoD funding mechanism for rare cancer research, please check out this free webinar, hosted by The NORD Rare Cancer Coalition on 5/2 https://t.co/cR1MKUmgwX
CancerLinQ and @count_me_in announce a new collaboration that will democratize patient participation in cancer research by allowing more patients with cancer to contribute to cancer discoveries and propel progress against cancer. Learn more ➡️ https://t.co/O4FSgsEfTG
P140: GENOMIC & TRANSCRIPTOMIC CORRELATES OF RESP TO ICI BLOCKADE-BASED THERAPY FOR #ANGIOSARCOMA PTS #CTOS2021 Evan Rosenbaum, @sandrapdangelo et al
~1/3 pts w AS treated w ICI derived benefit, many (not all) pts w cutaneous/H&N tumors & UV signature.
https://t.co/gY5iXuWoKO
Important #CancerTreatment progress for #Angiosarcoma from this @theNCI-funded study. Four of 16 patients partially or completely responded to treatment with a combo of #Immunotherapy drugs ipilimumab and nivolumab. Two other patients had stable disease >6 months. #RareCancers
Over 605 people have registered to participate in the Angiosarcoma Project since the project began. We have now received 276 saliva samples and 96 blood samples, and have obtained over 456 medical records and 218 tumor samples. https://t.co/2O3x4PcF6L
Broad, @DanaFarber, and @count_me_in launch research projects in two rare cancers, with focus on optimizing patient engagement; efforts aim to reveal rare cancer's genetic roots, mechanisms of drug resistance, and potential new treatment strategies. https://t.co/8XyVBV6Hj1
We have released another batch of data, bringing our numbers up to 83 clinically annotated WES samples from 62 patients. Please help us share this data both within the #sarcoma community and beyond to accelerate discoveries https://t.co/C6YHy8gWkq
If you haven't listened yet - here is just a lil snippet of our convo with the inspiring and yellow brick road builder @corrie_painter! Check out Ep. 6! #sarcoma#angiosarcoma#countmein https://t.co/WVUIQsTDpu